Michele A. Glinn, PhD, F-ABFT
Forensic Toxicologist and Scientific Director
Michele Glinn is a board-certified forensic toxicologist and current Scientific Director for Averhealth, a clinical and forensic laboratory located in St. Louis, MO. Dr. Glinn is a fellow of the American Board of Forensic Toxicology and holds a Clinical Laboratory Director Certification for the State of New York. She was previously an Assistant Director of the State Department of Toxicology in Indiana, the Program Coordinator of the Michigan State Police Toxicology Unit and the Laboratory Director for Essential Testing before joining Averhealth, initially as Laboratory Director and currently as Scientific Director. She has extensive experience analyzing multiple types of biological and non-biological samples for alcohol, drugs and contaminants as well as interpretation of results in all manner of forensic cases. She is also a qualified expert in breath alcohol testing and laboratory accreditation. She is a frequently requested expert witness in criminal and civil cases involving toxicology, having testified several hundred times in multiple states and federal court. She conducts frequent training sessions for law enforcement and drug court professionals, attorneys and judges and has appeared as a guest lecturer on forensic and clinical toxicology to pharmacy and forensic science students at the university level. She is a frequent consultant for criminal and civil attorneys as well as for clinical laboratory professionals and currently sits on several committees for the American Academy of Forensic Sciences Standards Board, the Society of Forensic Toxicologists and the Midwestern Association for Toxicology and Therapeutic Drug Monitoring.
Areas of Scientific Expertise
- Forensic and clinical toxicology
- Analysis of biological specimens for alcohol, drugs, chemicals and contaminants
- Breath alcohol testing
- Laboratory accreditation
- Scientific and technology
- Scientific and forensic evidence
- Expert Witnessing
- Taking It To The Extreme- A Very Extended Buprenorphine Half-Life, MATT Annual meeting, March 20, 2026"
- Ohio v. Michigan - Review of Unusual Cases, Cincinnati, OH, March 19, 2026
- Ask A Toxicologist, Averhealth, TN Association for Recovery Court Professionals, January 28, 2026
- New Cannabis Products and their Medical-Legal Effects, Kentucky Circuit Judge's College, KY Judicial Education Commission, October 22, 2025
- Ask a Toxicologist, Averhealth, RISE25, May 29, 2025
- CBD Conversion Conundrum, MATT Annual Meeting, April 3, 2025
- Old and New of Cannabis OWI, Prosecuting Attorneys Association of Michigan, Webinar, February 27, 2025
- A Review of the Cannabis Industry in 2023, MATT Annual Meeting, April 5, 2024
- Public Defender Continuing Education, Washtenaw Co. Webinar, June 9, 2023
- A View from Inside the Legal Cannabis Industry, MATT Annual Meeting, April 20, 2023
- Old and New of Cannabis OWI, Prosecuting Attorneys Association of Michigan Webinar, February 15, 2023
- Old and New of Cannabis OWI, Prosecuting Attorneys Association of Michigan Webinar, November 3, 2021
- Excuses I Have Known and Loved, MATT, "Virtual, April 27, 2021
- Old and New of Cannabis OWI, IMHM Webinar, April 14, 2021
- Old and New of Cannabis OWI, Prosecuting Attorneys Association of Michigan Webinar, February 24, 2021
- Guidelines for Opinion Testimony in Forensic Toxicology, Prosecuting Attorneys Association of Michigan Webinar, October 9, 2020
- DRE Evidence in Court, MJI Panel Discussion, November 14, 2019
- Prosecuting the Drugged Driver, Prosecuting Attorneys Association of Michigan Webinar, April 17, 2019
- A Biochip Screen for Drugs in Hair (poster), MATT, Cleveland, OH, April 5, 2019
- GLS Council, Gov. Law Section, Henry Hotel, February 8, 2019
- Gabapentin and Sexual Assault, SOFT, Minneapolis, MN, October 10, 2018
- DUID Testimony Workshop: Speaker & Moderator, SOFT, Minneapolis, MN, October 9, 2018
- Toxicology in Drugged Driving Cases, Prosecuting Attorneys Association of Michigan, Mt. Pleasant, MI, June 6, 2018
- Gabapentin and Sexual Assault, MATT, Indianapolis, IN, April 12, 2018
- Update on Fentanyl and NPS, Missouri Association of Treatment Court Professionals, Branson, MO, March 29, 2018
Refereed Journals
- Potency Levels of Regulated Cannabis Products in Michigan. Forensic Sci., 68(6), p. 1894-1905, 2023.
- Urinary Concentrations of Topically Administered Pain Medications. Analytical Toxicology, 41(2):127-133, 2017.
- Comparison of the Analytical Capabilities of the BAC Datamaster and Datamaster DMT Forensic Breath Testing Devices. Forensic Sci., 56(6):1632-8, 2011.
- Raloxifine and Estradiol Benzoate Both Fully Restore Hippocampal Choline Acetyltransferase Activity in Ovariectomized Rats. Brain Research, 847:98-104, 1999.
- α2-Macroglobulin Attenuates β-Amyloid Peptide 1-40 Fibril Formation and Associated Neurotoxicity of Cultured Fetal Rat Cortical Neurons. Neurochemistry., 70(3):1182-1188, 1998.
- Inorganic Pi increases Neuronal Survival in the Axute Early Phase Following Excitotoxic/Oxidative Insults. Neurochemistry, 70(5):1850-1858, 1998.
- α2-Macroglobulin as a β-Amyloid Peptide-Binding Plasma Protein. Neurochem., 69: 299-305, 1997.
- Inorganic Phosphate enhances phosphonucleotide concentrations in cultured fetal rat cortical neurons. Brain Research., 757:85-92, 1997.
- Phosphate Metabolism in Neurological Disorders (book chapter), World Health Organization, CH-1211 Geneva 27, Switzerland, 1998.
- Pro-and Anti-Oxidants Activities of the Mitochondrial Respiratory Chain: Factors Influencing NAD(P)H-Induced Lipid Peroxidation. Biophys. Acta-Bioenergetics, 1318: 246-254, 1997.
- Characterization of NA+-Dependent Phosphate Uptake in Cultured Fetal Rat Cortical Neurons. Neurochem., 65: 2358-2365, 1995.
- Structural Investigation of Catalytically Modified F120L and F120Y Semisynthetic Ribonucleases. Protein Science, 3:39-54, 1994.
- Initiation of Lipid Peroxidation in Submitochondrial Particles: Effect of Respiratory Inhibitors. Biochem. Biophys., 290 (1): 57-65, 1991.
- Characteristics of Individuals Who Do or Do Not Seek Treatment for Chronic Insomnia. Psychosomatics, 30(4): 421-427, 1989.
Case Reports
- Effects of Smokeless Tobacco and Belching on DMT Breath Alcohol Results, IACT Newsletter, August 2011.
- Physiological Effects of K2, PAAM Newsletter, Oct. 2010.
- How Many Drugs Does It Take to Prove Impairment? SOFT Newsletter, June 2008.
- Prolonged Residence Time of Benzoylecgonine in the Serum of a Chronic Drug User. MATT Newsletter, Oct. 2005.
- Richard H. Austin Traffic Safety Award for Long-Term Contributions to Traffic Safety, Toxicology/Blood Alcohol Unit, 2011
- Past-President, MATT, 2009-2010
- President, MATT, 2008 - 2009
- Vice President, MATT, 2007 - 2008
- Graduation magna cum laude from Wayne State University, 1993
- Thomas C. Rumble University Graduate Fellowship, Wayne State University,1990-1991 and 1992-1993 for academic merit.
- Graduation cum laude from Wayne State University, 1985
- Four-year full scholarship for undergraduate academic study, 1981-1985 from the Greater Detroit Chevrolet Dealers' Association for academic merit.
Committees
- American Academy of Forensic Toxicology Standards Board Committees (2016- present):
- Consensus Body for Toxicology
- Breath Alcohol Validation Standard Working Group
- Method Validation Working Group
- MATT Communications Committee (chair), 2023 – present
- SOFT Membership Committee, January 2026 - present
Click here to download her full resume.
